Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma

Recurrent gain on chromosome 3q26 encompassing the gene locus for the transcription factor SOX2 is a frequent event in human squamous cell carcinoma, including head and neck squamous cell carcinoma (HNSCC). Numerous studies demonstrated that SOX2 expression and function is related to distinct aspects of tumor cell pathophysiology. However, the underlying molecular mechanisms are not well understood, and the correlation between SOX2 expression and clinical outcome revealed conflicting data. Transcriptional profiling after silencing of SOX2 expression in a HNSCC cell line identified a set of up-regulated genes related to cell motility (e.g.

Source: Molecular Oncology - May 19, 2015 Category: Cancer & Oncology Authors: Pilar Bayo, Adriana Jou, Albrecht Stenzinger, Chunxuan Shao, Madeleine Gross, Alexandra Jensen, Niels Grabe, Christel Herold Mende, Pantelis Varvaki Rados, Juergen Debus, Wilko Weichert, Peter K. Plinkert, Peter Lichter, Kolja Freier, Jochen Hess Source Type: research